Drug
Atezolizumab
Atezolizumab: highest development phase Approved, developed by Arcus Biosciences, Aveo Pharmaceuticals, Jazz Pharmaceuticals and others. 8 trial records tracked on RxWires.
- Highest phase
- Approved
- Developer
- Arcus Biosciences, Aveo Pharmaceuticals, Jazz Pharmaceuticals
Trials
| Drug | Phase | Indication |
|---|---|---|
| TECENTRIQ | Approved | |
| Atezolizumab NCT04660344 | Phase 3 | Muscle-invasive Bladder Cancer |
| Atezolizumab NCT05482516 | Phase 3 | Colon Adenocarcinoma |
| Atezolizumab NCT05091567 | Phase 3 | Small-Cell Lung Cancer |
| Atezolizumab NCT03821246 | Phase 2 | Prostate Adenocarcinoma |
| Atezolizumab NCT05000294 | Phase 1/2 | Bile Duct Cancer |
| Atezolizumab NCT02350673 | Phase 1 | Solid Tumors |
| Atezolizumab NCT05542407 | Phase 1 | Endometrial Cancer |
Latest
Follow Atezolizumab on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.